Show simple item record

Authordc.contributor.authorCardiel, Mario H. 
Authordc.contributor.authorSoriano, Enrique R. 
Authordc.contributor.authorBonfá, Eloisa Silva Dutra De Oliveira 
Authordc.contributor.authorAlarcón, Graciela S. 
Authordc.contributor.authorIzcovich, Ariel 
Authordc.contributor.authorAmigo Castañeda, Mary Carmen 
Authordc.contributor.authorBarile-Fabris, Leonor A. 
Authordc.contributor.authorDuarte, Margarita 
Authordc.contributor.authorEspada, Graciela 
Authordc.contributor.authorGarcía, Mercedes A. 
Authordc.contributor.authorLevy, Roger A. 
Authordc.contributor.authorMassardo, Loreto 
Authordc.contributor.authorSato, Emilia I. 
Authordc.contributor.authorVásquez, Gloria 
Authordc.contributor.authorAcevedo Vásquez, Eduardo M. 
Authordc.contributor.authorCatoggio, Luis J. 
Authordc.contributor.authorChacón Díaz, Rosa 
Authordc.contributor.authorGalarza Maldonado, Claudio M. 
Authordc.contributor.authorIglesias Gamarra, Antonio J. 
Authordc.contributor.authorMolina Restrepo, José F. 
Authordc.contributor.authorNeira, Oscar 
Authordc.contributor.authorSilva, Clovis A. 
Authordc.contributor.authorVargas Peña, Andrea 
Authordc.contributor.authorPons Estel, Bernardo A. 
Cita de ítemdc.identifier.citationJournal of Clinical Rheumatology, Volumen 24, Issue 1, 2018, Pages 41-44
Abstractdc.description.abstractModern medicine is in a continuous state of flux given the relentless development of new evidence; thus, it is quite difficult for clinicians to remain abreast of all advances as they happen. Trustworthy clinical practice guidelines (CPGs) rigorously developed following a transparent methodology ( and including the best available evidence represent one of the best solutions to overcome these problems.1,2 Systemic lupus erythematosus is a complex multisystemic autoimmune disease. Limited epidemiological data on lupus are available in Latin America. In 1 study conducted in Argentina, the estimated prevalence of systemic lupus erythematosus was of 47 to 98 cases per 100,000 inhabitants.3 Because of the impact that ethnicity and poverty have on its presentation, activity, severity, and mortality,4 it is essential to develop guidelines for these patients.
Publisherdc.publisherLippincott Williams and Wilkins
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.uri
Sourcedc.sourceJournal of Clinical Rheumatology
Títulodc.titleTherapeutic Guidelines for Latin American Lupus Patients: Methodology
Document typedc.typeArtículo de revista
Indexationuchile.indexArtículo de publicación SCOPUS

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile